The pills haven't been compared head-to-head in a clinical trial, but in separate studies, the Wegovy pill showed average weight loss of 14% over 64 weeks, compared with 2% for a placebo, while orforglipron showed 11% weight loss over 72 weeks on its highest dose, compared with 2% for the placebo group
Step 2: Explain GLP-1 and Its Function Clearly explain what GLP-1 is and how it works in simple terms
Hadidchi ensures that each patient receives regular follow-ups to assess the effectiveness of the medication
Finally, long-term safety, treatment persistence, cost-effectiveness, and identification of patient subgroups most likely to benefit from dual therapy remain uncertain
In a Southern Italian cohort of 516 individuals aged 65106, a notable trend in leukocyte telomere length was observed, with a decline post-70 years and a subsequent increase after 92 years, paralleling demographic survival curves